Marc A. Rodwin

1.3k total citations
65 papers, 727 citations indexed

About

Marc A. Rodwin is a scholar working on Economics and Econometrics, Pharmacology and General Health Professions. According to data from OpenAlex, Marc A. Rodwin has authored 65 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Economics and Econometrics, 31 papers in Pharmacology and 21 papers in General Health Professions. Recurrent topics in Marc A. Rodwin's work include Pharmaceutical industry and healthcare (31 papers), Healthcare Policy and Management (23 papers) and Pharmaceutical Economics and Policy (16 papers). Marc A. Rodwin is often cited by papers focused on Pharmaceutical industry and healthcare (31 papers), Healthcare Policy and Management (23 papers) and Pharmaceutical Economics and Policy (16 papers). Marc A. Rodwin collaborates with scholars based in United States, France and United Kingdom. Marc A. Rodwin's co-authors include John Abramson, Wendy Lipworth, Ian Kerridge, Sydney A. Halpern, Ray Moynihan, Hazel Thornton, Minna Johansson, Beate Wieseler, Helen Macdonald and Ming Tai‐Seale and has published in prestigious journals such as New England Journal of Medicine, JAMA and Contemporary Sociology A Journal of Reviews.

In The Last Decade

Marc A. Rodwin

60 papers receiving 685 citations

Peers

Marc A. Rodwin

EE

PHARM

GHP

PHEOH

PHARM

Janlori Goldman United States

Carol R. Horowitz United States

Merrill Goozner United States

Athanassios Vozikis Greece

Deborah Cohen United States

Robert Leitman United States

Daniel Wiesen Germany

Sharona Hoffman United States

Daniella A. Zipkin United States

Leila Agha United States

Janlori Goldman United States

Marc A. Rodwin

312 ×1.0

EE

406 ×1.4

PHARM

230 ×0.9

GHP

230 ×1.1

PHEOH

13 ×0.1

PHARM

Citations per year, relative to Marc A. Rodwin Marc A. Rodwin (= 1×) peers Janlori Goldman

Countries citing papers authored by Marc A. Rodwin

Since Specialization

Citations

This map shows the geographic impact of Marc A. Rodwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc A. Rodwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc A. Rodwin more than expected).

Fields of papers citing papers by Marc A. Rodwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc A. Rodwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc A. Rodwin. The network helps show where Marc A. Rodwin may publish in the future.

Co-authorship network of co-authors of Marc A. Rodwin

This figure shows the co-authorship network connecting the top 25 collaborators of Marc A. Rodwin. A scholar is included among the top collaborators of Marc A. Rodwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc A. Rodwin. Marc A. Rodwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Rodwin, Marc A., Julien Mancini, Ségolène Duran, et al.. (2021). The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004–2017. European Journal of Cancer. 145. 11–18. 10 indexed citations

2.

Rodwin, Marc A.. (2019). Conflict of Interest in the Pharmaceutical Sector: A Guide for Public Management. Digital Commons-DePaul (DePaul University). 21(1). 3. 4 indexed citations

3.

Moynihan, Ray, Lisa Bero, Sue Hill, et al.. (2019). Pathways to independence: towards producing and using trustworthy evidence. BMJ. 367. l6576–l6576. 61 indexed citations

4.

Rodwin, Marc A.. (2018). Conflicts of Interest in Medicine: Should We Contract, Conserve, or Expand the Traditional Definition and Scope of Regulation?. 21(2). 157. 3 indexed citations

5.

Kerridge, Ian, et al.. (2018). Should we try to manage non-financial interests?. BMJ. 361. k1240–k1240. 28 indexed citations

6.

Rodwin, Marc A., et al.. (2015). Why the Medical Malpractice Crisis Persists Even When Malpractice Insurance Premiums Fall.. PubMed. 25. 163–226. 1 indexed citations

7.

Rodwin, Marc A.. (2015). Independent Drug Testing to Ensure Drug Safety and Efficacy. 18(1). 45. 3 indexed citations

8.

Rodwin, Marc A.. (2013). Rooting Out Institutional Corruption to Manage Inappropriate Off-Label Drug Use. The Journal of Law Medicine & Ethics. 41(3). 654–664. 1 indexed citations

9.

Rodwin, Marc A.. (2013). Institutional Corruption and the Pharmaceutical Policy. The Journal of Law Medicine & Ethics. 41(3). 544–552. 2 indexed citations

10.

Rodwin, Marc A.. (2013). Five Un-Easy Pieces of Pharmaceutical Policy Reform. The Journal of Law Medicine & Ethics. 41(3). 581–589. 3 indexed citations

11.

Rodwin, Marc A.. (2012). Independent Clinical Trials to Test Drugs: The Neglected Reform. 6(1). 7. 4 indexed citations

12.

Rodwin, Marc A.. (2012). Conflicts of Interest, Institutional Corruption, and Pharma: An Agenda for Reform. The Journal of Law Medicine & Ethics. 40(3). 511–522. 31 indexed citations

13.

Rodwin, Marc A.. (2011). Conflicts of Interest and the Future of Medicine: The United States, France, and Japan. RePEc: Research Papers in Economics.

14.

Rodwin, Marc A.. (2011). Reforming Pharmaceutical Industry-Physician Financial Relationships: Lessons from the United States, France, and Japan. The Journal of Law Medicine & Ethics. 39(4). 662–670. 1 indexed citations

15.

Rodwin, Marc A.. (2010). Drug Advertising, Continuing Medical Education, and Physician Prescribing: A Historical Review and Reform Proposal. The Journal of Law Medicine & Ethics. 38(4). 807–815. 4 indexed citations

16.

Rodwin, Marc A.. (2009). The Case for Public Ownership of Patient Data. JAMA. 302(1). 86–86. 34 indexed citations

17.

Rodwin, Marc A., et al.. (2000). Physicians' Conflicts of Interest in Japan and the United States: Lessons for the United States. Journal of Health Politics Policy and Law. 25(2). 343–376. 9 indexed citations

18.

Rodwin, Marc A.. (1999). Exit and Voice in American Health Care. University of Michigan Journal of Law Reform. 32(4). 1041–1067. 2 indexed citations

19.

Rodwin, Marc A.. (1998). Conflicts of Interest and Accountability in Managed Care: The Aging of Medical Ethics. Journal of the American Geriatrics Society. 46(3). 338–341. 4 indexed citations

20.

Altman, Stuart H. & Marc A. Rodwin. (1988). Halfway Competitive Markets and Ineffective Regulation: The American Health Care System. Journal of Health Politics Policy and Law. 13(2). 323–339. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact